MODIFICATION
65 -- AVAILABILTY OF INTRAVENOUS MEDICATION ADMINISTRATION SUPPLIES
- Notice Date
- 4/2/2012
- Notice Type
- Modification/Amendment
- NAICS
- 423450
— Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
- Contracting Office
- Department of Health and Human Services, Centers for Disease Control and Prevention, Procurement and Grants Office (Atlanta), 2920 Brandywine Road, Room 3000, Atlanta, Georgia, 30341-4146
- ZIP Code
- 30341-4146
- Solicitation Number
- RFI-44923
- Archive Date
- 4/28/2012
- Point of Contact
- Christine N Godfrey, Phone: 770-488-2519
- E-Mail Address
-
cnp9@cdc.gov
(cnp9@cdc.gov)
- Small Business Set-Aside
- N/A
- Description
- REQUEST FOR INFORMATION (RFI) FOR AVAILABILTY OF INTRAVENOUS MEDICATION ADMINISTRATION SUPPLIES ISSUED BY: The Centers for Disease Control and Prevention's Division of Strategic National Stockpile (DSNS) BACKGROUND: The Centers for Disease Control and Prevention's (CDC) Strategic National Stockpile (SNS) is a national repository of pharmaceuticals and medical supplies designed to supplement and re-supply state and local public health agencies during a national emergency. The DSNS is considering alternate options for optimizing response capabilities and obtaining medical supplies needed to support a national health emergency. One option would be to procure certain medical supplies at the time of such an event. The DSNS is interested in obtaining information from manufacturers and distributors about the quantity and types of intravenous medication administration supplies that are available within their facilities daily. The DSNS is also interested in manufacturer ramp up time to produce additional intravenous medication administration supplies at the time of a national emergency; this would include time and quantity estimates. PURPOSE: This notice is being issued by the CDC's Procurements and Grants Office (PGO) to conduct market research in order to determine manufacturer and distributor capabilities to support and assist the Federal government during a national health emergency. CAPABILITIES TABLE: To respond to this RFI, please complete the table on page 3 using the following list of medication administration supplies. The DSNS acknowledges that any one entity may not be able to produce or acquire all the below items and so asks that you provide information only for those items that apply to your company. It is also acknowledged that some companies might refer to certain products listed below by a similar (but different) name. Respondents should reference their specific item descriptions in the capability table. INTRAVENOUS MEDICATION ADMINISTRATION SUPPLIES (General Item Descriptions) IV administration set 10 drop, dual vented, with 2-3 luer lock injection sites IV administration set 10 drop, unvented, with 2-3 luer lock injection sites IV administration set 10 drop, vented, with 2-3 luer lock injection sites IV administration set 15 drop, dual vented, with 2-3 luer lock injection sites IV administration set 15 drop, unvented, with 2-3 luer lock injection sites IV administration set 15 drop, vented, with 2-3 luer lock injection sites IV administration set 60 drop, dual vented, with 2-3 luer lock injection site IV administration set 60 drop, unvented, with 2-3 luer lock injection site IV administration set 60 drop, vented, with 2-3 luer lock injection site IV secondary/piggyback set, dual vented, luer lock IV secondary/piggyback set, unvented, luer lock IV 18g x 1 ¼" angio or insyte catheter, shielded IV 18g x 2" angio or insyte catheter, shielded IV 20g x 1 ¼" angio or insyte catheter, shielded IV 20g x 1" angio or insyte catheter, shielded IV 21g x ¾" angio or insyte catheter, shielded IV 22g x 1" angio or insyte catheter, shielded IV 24g x ¾" angio or insyte catheter, shielded IV start kit (contents: alcohol pads, latex-free tourniquet, 2x2 gauze, transparent IV dressing, clear tape, IV extension, IV stabilizer) IV start kit (contents: alcohol pads, latex-free tourniquet, 2x2 gauze, transparent IV dressing, clear tape) IV site transparent dressing IV catheter stabilizer and extension set IV pumps IV syringe pumps Dial-o-flo or Control-a-flo (manual IV drip regulator) Tourniquet, latex free Alcohol pads Clear tape 1" Antimicrobial heparin lock, luer lock, pre-pierced Saline 5cc prefilled syringe, luer lock Saline 3cc prefilled syringe, luer lock Blunt plastic needles, luer lock (to attach to saline syringes, for injection) MANUFACTURER/DISTRIBUTOR INTRAVENOUS MEDICATION ADMINISTRATION SUPPLY CAPABILITY Please see the attached table for response submission. RESPONSE INSTRUCTIONS AND PROCESS: All entities expressing an interest in this RFI shall provide the following information: a. Name and address of company b. Primary point of contact information (name, phone number, email address) c. A completed capabilities table (attached to the listing) Responses must be submitted electronically to cgodfrey@cdc.gov by no later than 2:00 p.m. (Eastern Daylight Time) on April 13, 2012. Please put "RFI # 44923" in the email subject line. Telephone calls will not be accepted. However, a teleconference to answer any questions from interested entities may be held on April 5th. Please indicate your interest in participation via email to the address above by 2:00 p.m. (EDT) March 30, 2012. If there is interest, call-in information will be provided on Federal Business Opportunities by April 2, 2012. Teleconference call information: Date: April 5th, Time: 12:00- 1:30 PM EDT, Bridgeline: 1-866-745-1161, Participant code: 1629792 For those participants who are interested, but unable to be apart of the conference call, the questions and answers will be posted on this website for viewing. This RFI is issued solely for information and planning purposes and does not constitute a solicitation or issuance thereof. All information received in response to this RFI that is marked proprietary will be handled accordingly. Responses to this RFI will not be returned. Responses to this RFI are not offers and cannot be accepted by the Government to form a binding contract or award. However, the information received through this RFI will be utilized to assist in acquisition planning for procurements. Responders are solely responsible for all expenses associated with responding to this RFI.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/CDCP/PGOA/RFI-44923/listing.html)
- Place of Performance
- Address: 1600 Clifton Road, Atlanta, Georgia, 30333, United States
- Zip Code: 30333
- Zip Code: 30333
- Record
- SN02711422-W 20120404/120402234834-8f4392a3311e66b85f13a129281a2191 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |